CVE-2022-48226 Privilege escalation in n/a
A local attacker can achieve elevated code execution by pre-creating a file in the Windows Temp directory during the SDK installation process.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Local or same network only
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2022-48226?
CVE-2022-48226 is a high-severity vulnerability in n/a, published on 4 Apr 2023. It can only be exploited from the same machine or local network, with no action from the victim.
Official description
An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.
Weakness: CWE-269
Which versions are affected by CVE-2022-48226?
It affects 1 product.
Products include Gbgplc Acuant Acufill Sdk.
How do I fix CVE-2022-48226?
No fix has been published for CVE-2022-48226 yet. Limit exposure of the affected software until one is available.
Is CVE-2022-48226 being exploited?
There is no known exploitation of CVE-2022-48226 in the wild and no public exploit code.
Other vulnerabilities in n/a
Sources
Also known as GHSA-g8h8-pg73-gcw3.